866-997-4948(US-Canada Toll Free)

Cardiac Resynchronization Therapy Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Mar 2018

Category :

Therapeutic Area

No. of Pages : 156 Pages

Global Cardiac Resynchronization Therapy Systems Market: Scope and Methodology

This report on the global Cardiac Resynchronization Therapy Systems Market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global diabetes devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global diabetes devices market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of various segments of global Cardiac Resynchronization Therapy Systems Market.

Cardiac Resynchronization Therapy Systems Market: Segmentation

Prevalence of heart failure is expected to increase exponentially worldwide due to change in lifestyle and various factors such as malnutrition, genetic mutations, and others. According to various government and private organizations operating in the cardiovascular industry, heart failure is considered one of the top reasons of mortality worldwide. Globally 26 million people are affected by heart failure.  Cardiac resynchronization therapy (CRT) systems are used to treat conditions such as heart failure. The global Cardiac Resynchronization Therapy Systems Market can be segmented based on product type and region.

Depending on the product type the global Cardiac Resynchronization Therapy Systems Market includes - Cardiac Resynchronization Therapy Pacemaker and Cardiac Resynchronization Therapy Defibrillator. Cardiac resynchronization therapy pacemaker (CRT-P) also known as bi ventricular pacing is an implantable cardiac resynchronization therapy (CRT) pacemaker for patients with heart failure. The device monitors the heart's rhythm, detects irregularities and corrects them with electrical impulses. Cardiac resynchronization therapy defibrillator (CRT-D) is implanted in heart failure patients who are at a high risk of sudden cardiac arrest.

Cardiac Resynchronization Therapy Systems Market: Geographical and Competitive Dynamics

Geographically, the global Cardiac Resynchronization Therapy Systems Market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the Cardiac Resynchronization Therapy Systems Market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Medtronic, Boston Scientific Corporation, Abbott, LivaNova PLC, BIOTRONIK SE & Co. KG

The global Cardiac Resynchronization Therapy Systems Market is segmented as follows:

Global Cardiac Resynchronization Therapy Systems Market Revenue, by Product type

  • Cardiac Resynchronization Therapy Pacemaker
  • Cardiac Resynchronization Therapy Defibrillator

Global Cardiac Resynchronization Therapy Systems Market Revenue, by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Research Approach & Methodology

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Global Diabetes Device Market Analysis and Forecasts, 2017–2025
4.3. Global Cardiac Resynchronization Therapy Systems Market Outlook
4.4. Porter’s Five Forces Analysis
4.5. Value Chain Analysis
4.6. Global Prevalence of Heart Failure
4.7. Recommendations for Cardiac Resynchronization Therapy (CRT)
4.8. Regulatory Framework

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends

6. Global Cardiac Resynchronization Therapy Systems Market Analysis, and Forecast by Product Type
6.1. Introduction & Definition
6.2. Global Cardiac Resynchronization Therapy Systems Market Analysis, by Product Type
6.2.1. Global Cardiac Resynchronization Therapy Systems Market Forecast, by Product Type
6.2.2. Cardiac Resynchronization Therapy Pacemaker
6.2.3. Cardiac Resynchronization Therapy Defibrillator

7. Global Cardiac Resynchronization Therapy Systems Market Analysis and Forecasts, By Region
7.1. Global Cardiac Resynchronization Therapy Systems Snapshot, by Country
7.2. Market Value Forecast By Region
7.3.1. North America 
7.3.2. Europe 
7.3.3. Asia Pacific 
7.3.4. Middle East & Africa 
7.3.5. Latin America 
7.4. Market Attractiveness By Country/Region

8. North America Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Trends
8.2. Market Value Forecast By Product Type , 2017–2025
8.2.1. Cardiac Resynchronization Therapy Pacemaker
8.2.2. Cardiac Resynchronization Therapy Defibrillator
8.3. Market Value Forecast By Country , 2017–2025
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis 
8.4.1. By Product Type 
8.4.2. By Country

9. Europe Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Trends
9.2. Market Value Forecast By Product Type , 2017–2025
9.2.1 Cardiac Resynchronization Therapy Pacemaker
9.2.2. Cardiac Resynchronization Therapy Defibrillator
9.3. Market Value Forecast By Country , 2017–2025
9.3.1. Germany
9.3.2. France
9.3.3. Italy
9.3.4. Spain
9.3.5. U.K.
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis 
9.4.1. By Product Type 
9.4.2. By Country

10. Asia Pacific Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Trends
10.2. Market Value Forecast By Product Type , 2017–2025
10.2.1. Cardiac Resynchronization Therapy Pacemaker
10.2.2. Cardiac Resynchronization Therapy Defibrillator
10.3. Market Value Forecast By Country , 2017–2025
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis 
10.4.1. By Product Type 
10.4.2. By Country

11. Middle East & Africa Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Trends
11.2. Market Value Forecast By Product Type, 2017–2025
11.2.1. Cardiac Resynchronization Therapy Pacemaker
11.2.2. Cardiac Resynchronization Therapy Defibrillator
11.3. Market Value Forecast By Country, 2017–2025
11.3.1. GCC Countries
11.3.2. South Africa
11.3.3. Rest of MEA
11.4. Market Attractiveness Analysis 
11.4.1. By Product Type 
11.4.2. By Country

12. Latin America Cardiac Resynchronization Therapy Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Trends
12.2. Market Value Forecast By Product Type, 2017–2025
12.2.1. Cardiac Resynchronization Therapy Pacemaker
12.2.2. Cardiac Resynchronization Therapy Defibrillator
12.3. Market Value Forecast By Country, 2017–2025
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Market Attractiveness Analysis 
12.4.1. By Product Type 
12.4.2. By Country

13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.2.1. Medtronic
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Financial Overview
13.2.1.3. Product Portfolio
13.2.1.4. SWOT Analysis
13.2.1.5. Strategic Overview
13.2.2. Boston Scientific Corporation
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Financial Overview
13.2.2.3. Product Portfolio
13.2.2.4. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3. Abbott
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Financial Overview
13.2.3.3. Product Portfolio
13.2.3.4. SWOT Analysis
13.2.3.5. Strategic Overview
13.2.4. LivaNova PLC
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Financial Overview
13.2.4.3. Product Portfolio
13.2.4.4. SWOT Analysis
13.2.4.5. Strategic Overview
13.2.5. BIOTRONIK SE & Co. KG 
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Financial Overview
13.2.5.3. Product Portfolio
13.2.5.4. SWOT Analysis
13.2.5.5. Strategic Overview
13.2.6. Asahi Kasei Medical Co., Ltd.
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Financial Overview
13.2.6.3. Product Portfolio
13.2.6.4. SWOT Analysis
13.2.6.5. Strategic Overview
13.2.7. NIHON KOHDEN CORPORATION
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Financial Overview
13.2.7.3. Product Portfolio
13.2.7.4. SWOT Analysis
13.2.7.5. Strategic Overview
13.2.8. Schiller AG
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Financial Overview
13.2.8.3. Product Portfolio
13.2.8.4. SWOT Analysis
13.2.8.5. Strategic Overview

List of Table

Table 01: Opportunity Map, 2016
Table 02: Global Prevalence of Heart Failure (2015)
Table 03: Global Cardiac Resynchronization Therapy Systems Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 04: Global Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Cardiac Resynchronization Therapy Systems Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 06 North America Cardiac Resynchronization Therapy Systems Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 07: Europe Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 08: Europe Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 09: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 10: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 11: Latin America Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 12: Latin America Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 13: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 14: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Medtronic, Products & Services Offered
Table 16: Medtronic Recent Developments 
Table 17 :Boston Scientific Corporation,  Products & Services Offered
Table 18: Boston Scientific Corporation, Recent Developments 
Table 19: Abbott, Products & Services Offered
Table 20: Abbott, Recent Developments 
Table 21: LivaNova PLC, Products & Services Offered
Table 22: LivaNova PLC , Recent Developments 
Table 23: BIOTRONIK SE & Co. KG , Products & Services Offered
Table 24: Asahi Kasei Medical Co., Ltd., Products & Services Offered
Table 25: Asahi Kasei Medical Co., Ltd., Recent Developments and Achievements
Table 26: NIHON KOHDEN CORPORATION, Products Offered
Table 27: NIHON KOHDEN CORPORATION, Recent Developments
Table 28: Schiller, Products Offered

List of Chart

Figure 01: Global Cardiac Resynchronization Therapy Systems Market, by Product Type, Market Size (US$ Mn), 2017 (E)
Figure 02: Global Cardiac Resynchronization Therapy Systems Market Revenue (%), by Region, 2017 (E)
Figure 03: Executive Summary (2/3)
Figure 04: Executive Summary (3/3)
Figure 05: Key Industry Events and Developments
Figure 06: Global Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, 2015–2025
Figure 07: Global Cardiac Resynchronization Therapy Systems Market Value Share, by product type (2016)
Figure 08: Global Cardiac Resynchronization Therapy Systems Market Value Share, by  Region (2016)
Figure 09: Global Cardiac Resynchronization Therapy Systems Market
Figure 10: Global Cardiac Resynchronization Therapy Systems Market Value Share, by product Type, 2017 and 2025
Figure 11: Global Cardiac Resynchronization Therapy Systems Market Attractiveness, by Product Type, 2017–2025
Figure 12: Global Cardiac Resynchronization Therapy Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CRT-P, 2015–2025
Figure 13: Global Cardiac Resynchronization Therapy Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CRT-D, 2015–2025
Figure 14: Global Cardiac Resynchronization Therapy Systems Snapshot, by Country (1/1)
Figure 15: Global Cardiac Resynchronization Therapy Systems Value Share, by Region, 2017 and 2025 
Figure 16: Global Cardiac Resynchronization Therapy Systems Attractiveness, by Region, 2017–2025
Figure 17: North America Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 18: North America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 19: North America Cardiac Resynchronization Therapy Systems Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 20: North America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
Figure 21: North America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country
Figure 22: Drivers Impact Analysis for North America
Figure 23: Europe Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 24: Europe Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 25: Europe Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
Figure 26: Europe Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
Figure 27: Europe Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region
Figure 28: Drivers Impact Analysis for Europe
Figure 29: Asia Pacific Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 30: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 31: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
Figure 32: Asia Pacific Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
Figure 33: Asia Pacific Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country 
Figure 34: Drivers Impact Analysis for Asia Pacific
Figure 35: Latin America Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 36: Latin America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 37: Latin America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
Figure 38: Latin America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
Figure 39: Latin America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region
Figure 40: Drivers Impact Analysis for Latin America
Figure 41: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 42: Middle East &Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 43: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
Figure 44: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
Figure 45: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region
Figure 46: Drivers Impact Analysis for Middle East & Africa
Figure 47: Competition Matrix (1/1)
Figure 48: Competition Matrix (2/2) 
Figure 49: Medtronic, R&D Spending and Sales & Distribution Spending– Company Level or Segment Level, 2015–2016
Figure 50: Medtronic, Breakdown of Net Sales, by Business Segments, 2017
Figure 51 :Medtronic, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2017
Figure 52: Medtronic, Breakdown of Net Sales, By Region 2017
Figure 53: Boston Scientific Corporation, R&D Spending (Mn) and Sales & Distribution Spending (Mn) – Company Level or Segment Level, 2015–2016
Figure 54: Boston Scientific Corporation, Breakdown of Net Sales, by Business Segments, 2017
Figure 55 :Boston Scientific Corporation, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2017
Figure 56:Boston Scientific Corporation, Breakdown of Net Sales, By Region 2017
Figure 57:Abbott, R&D Spending and Sales & Distribution Spending– Company Level or Segment Level, 2015–2016
Figure 58: Abbott, Breakdown of Net Sales, by Business Segments, 2017
Figure 59: Abbott, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2017
Figure 60: Abbott, Breakdown of Net Sales, By Region 2017
Figure 61: LivaNova PLC, R&D Spending and Sales & Distribution Spending (US$ Mn)– Company Level or Segment Level, 2015–2016
Figure 62: LivaNova PLC, Breakdown of Net Sales, by Business Segments, 2017
Figure 63 : LivaNova PLC, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2017
Figure 64: LivaNova PLC, Breakdown of Net Sales, By Region 2017
Figure 65: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2012–2015
Figure 66: Asahi Kasei Medical Co., Ltd. R&D Intensity and Sales & Marketing Intensity Company Level, 2015–2016
Figure 67: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales, By Region (Segment Level-Connected Care & Health Informatics) 2016
Figure 68: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales, By Business Segments (Company Level) 2016
Figure 69: NIHON KOHDEN CORPORATION Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 70: NIHON KOHDEN CORPORATION R&D Intensity and Sales & Marketing Intensity (US$ Mn) – Company Level, 2016–2017
Figure 71: NIHON KOHDEN CORPORATION Breakdown of Net Sales, By Region (Company Level), March 31, 2017
Figure 72: NIHON KOHDEN CORPORATION Breakdown of Net Sales, By Business Segments March 31, 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *